BLOOMINGTON, Ind.–(BUSINESS WIRE)–Cook Medical’s Endoscopy business unit redefines access with the introduction of their latest wire guide, the next generation Acrobat® 2 Calibrated Tip Wire Guide. The Acrobat 2 provides the tip flexibility needed for ductal navigation. “We’re very excited to launch the Acrobat 2 wire guide” “We’re very excited […]
Radiology
SIRT is better tolerated than sorafenib, but doesn’t increase overall survival in HCC
PUBLIC RELEASE: 22-APR-2017 April 22, 2017, Amsterdam, The Netherlands: Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival (OS) of 8.0 months compared to 9.9 months with sorafenib (p=0.179), in patients with locally advanced and inoperable hepatocellular carcinoma (HCC). The trial, presented at The International […]
First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads
NEWS PROVIDED BY BTG Plc – 20 Apr, 2017, 02:00 ET LONDON, April 20, 2017 /PRNewswire/ — BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™. Two patients were treated for hepatocellular carcinoma (HCC) and one […]
Medical Groups Unite in Support of Science
NEWS PROVIDED BY American Society of Hematology 17 Apr, 2017, 08:38 ET WASHINGTON, April 17, 2017 /PRNewswire-USNewswire/ — As the world’s leading organizations representing clinicians, laboratory researchers, and physician-scientists committed to improving patient care, we support the March for Science and its nonpartisan call for the appreciation of scientific evidence, education, and investment. Science […]
Inari Medical Announces First Patient Treated with the ClotTriever™ Thrombectomy System
NEWS PROVIDED BY | Inari Medical Inc. | 10 Apr, 2017, 09:00 ET IRVINE, Calif., April 10, 2017 /PRNewswire/ — Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of venous thrombus, announced the treatment of the first patient with its ClotTriever Thrombectomy System. The ClotTriever Thrombectomy System received […]
REVA Receives CE Mark for Fantom
SAN DIEGO, April 03, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce it has received CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold, which offers multiple and substantial performance advantages over first-generation scaffolds on the market today. Fantom is REVA’s […]
Utah’s Merit Medical (MMSI) Prices $136.5 Million Offering
Merit Medical Announces Closing of Public Offering of Common Stock SOUTH JORDAN, Utah, March 29, 2017 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that […]
Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
BOTHELL, Wash., March 23, 2017 /PRNewswire/ — Mirabilis Medical, a Seattle-area developer of advanced medical technology for non-invasive surgery, announced today CE Mark authorization for marketing of the Mirabilis System for treatment of uterine fibroids throughout the European Union. The company simultaneously announced that it had received approval from the US […]
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., March 14, 2017 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced it has received CE Mark certification for the Solero Microwave Tissue Ablation (MTA) System. The Solero MTA System and Accessories are […]
Humacyte Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Expedited Review Designation for HUMACYL® in Vascular Access for Hemodialysis
Press Release RESEARCH TRIANGLE PARK, N.C. — Humacyte, an innovator in biotechnology and regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted HUMACYL®, its investigational human acellular vessel (HAV), the Regenerative Medicine Advanced Therapy (RMAT) designation. This designation means that the FDA will help facilitate […]